November 2008 saw the draft publication of
the FDA’s long anticipated Guidance for
Industry on ‘Process Validation: General
Principles and Practices’. It outlines the FDA’s
current thinking on process validation for the
manufacture of Human and Veterinary drugs
including Biologicals and APIs.